IPP Bureau
Cell and gene therapy will be top industry trend for pharma in 2024, finds GlobalData
By IPP Bureau - January 02, 2024
The survey data presented in “The State of the Biopharmaceutical Industry 2024” report reveals that N=21 (18%) of industry professionals were convinced that CGT will dominate as the most important trend in pharma next year
Palatin completes sale of Vyleesi to Cosette Pharmaceuticals for up to $171 mn
By IPP Bureau - January 02, 2024
Vyleesi is the first and only as-needed treatment approved by the Food and Drug Administration (FDA) for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)
Enpro to acquire Advanced Micro Instruments
By IPP Bureau - January 02, 2024
AMI to become part of Enpro’s Sealing Technologies Segment
Inspira Technologies closes on $3.88 million RDO
By IPP Bureau - January 02, 2024
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering
Ami Organics increases its stake by 1%
By IPP Bureau - January 02, 2024
Ami Organics recently announced contract with global MNC for manufacturing of electrolyte for battery cells
Sun Pharma to acquire 16.7% stake in Lyndra Therapeutics for $30 mn
By IPP Bureau - January 02, 2024
According to Sun Pharma, the purpose of the strategic investment is to obtain access to the technology for certain compounds and territories while also fostering the development of novel pharmaceutical delivery systems.
Roche to buy LumiraDx’s technology platform for US$ 295 million
By IPP Bureau - December 31, 2023
Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million
Alkem completes sale of St. Louis manufacturing facility for US$ 7.96 million
By IPP Bureau - December 31, 2023
The unit’s contribution to the company's revenue US$3.85 million in the last fiscal year
Adani and Sirius form JV to digitally transform India's digital economy
By IPP Bureau - December 31, 2023
Sirius JV will be owned 51% by Sirius and 49% by Adani
Venus Remedies secures marketing approval from Israel, Colombia for two oncology drugs
By IPP Bureau - December 30, 2023
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
Qure solidifies its position as innovation powerhouse with 26 patents
By IPP Bureau - December 30, 2023
Marks remarkable acceleration in innovation using AI technology
Dr. Reddy's Laboratories acquires Preferred A-1 shares of Edity Therapeutics
By IPP Bureau - December 30, 2023
The acquisition is done through cash consideration, by way of conversion of SAFE (Simple Agreement for Future Equity) investment of US$ 2 Million to Preferred A-1 Shares
Karkions Healthcare bags DSCI Excellence Award 2023
By IPP Bureau - December 29, 2023
Karkinos Healthcare has demonstrated exceptional dedication to privacy, setting a commendable example for businesses navigating the complexities of the digital landscape
Akums to empower mothers with Doxylamine + Pyridoxine extended-release tablets for severe morning sickness
By IPP Bureau - December 28, 2023
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
Ecolab recognised by DJSI World and North America Indices
By IPP Bureau - December 28, 2023
Ecolab’s continued leadership position on renowned sustainability indices demonstrates the company’s record of advancing sustainable growth
